Hypersensitivity to Amylin in Post-Traumatic Headache
ClinicalTrials.gov · NCT07340775 · Registry updated: 2026-11-20
- Condition / research focus
- Headache Disorders, Secondary; Brain Diseases; Headache Disorders; Nervous System Diseases; Central Nervous System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Post-Traumatic Headache; Pain; Peptide Hormones; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Peptides; Amino Acids, Peptides, and Proteins; Amylin; Pramlintide
- Sponsor
- Danish Headache Center
- Countries with listed sites
- Denmark
- Registry dates and results
- Start: 2026-11-27. Completion: 2028-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Amylin (drug)
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Rigshospitalet Glostrup
Glostrup Municipality, Denmark
Site recruitment: Recruiting